KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) EBT (2016 - 2025)

Historic EBT for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to $17.1 million.

  • Repligen's EBT rose 158929.5% to $17.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.6 million, marking a year-over-year decrease of 25035.22%. This contributed to the annual value of -$89.3 million for FY2024, which is 20946.87% down from last year.
  • As of Q3 2025, Repligen's EBT stood at $17.1 million, which was up 158929.5% from $18.2 million recorded in Q2 2025.
  • In the past 5 years, Repligen's EBT registered a high of $59.8 million during Q2 2022, and its lowest value of -$100.9 million during Q4 2024.
  • Over the past 5 years, Repligen's median EBT value was $24.9 million (recorded in 2023), while the average stood at $21.5 million.
  • Per our database at Business Quant, Repligen's EBT plummeted by 47713.15% in 2024 and then soared by 158929.5% in 2025.
  • Quarter analysis of 5 years shows Repligen's EBT stood at $34.8 million in 2021, then surged by 52.05% to $53.0 million in 2022, then tumbled by 49.51% to $26.8 million in 2023, then tumbled by 477.13% to -$100.9 million in 2024, then skyrocketed by 116.96% to $17.1 million in 2025.
  • Its last three reported values are $17.1 million in Q3 2025, $18.2 million for Q2 2025, and $7.9 million during Q1 2025.